References
- Shi HM, Wang J, Wang MY, et al. Identification of Cistanche species by chemical and inter-simple sequence repeat fingerprinting. Biol Pharm Bull 2009;32:142–6
- Jia Y, Guan Q, Jiang Y, et al. Amelioration of dextran sulphate sodium-induced colitis in mice by echinacoside-enriched extract of Cistanche tubulosa. Phytother Res 2014;28:110–19
- Brown PN, Chan M, Paley L, Betz JM. Determination of major phenolic compounds in Echinacea spp. raw materials and finished products by high-performance liquid chromatography with ultraviolet detection: single-laboratory validation matrix extension. J Aoac Int 2011;94:1400–10
- Sasaki H, Nishimura H, Morota T, et al. Immunosuppressive principles of Rehmannia glutinosa var. hueichingensis1. Planta Med 1989;55:458–62
- Xie J, Deng J, Tan F, Su J. Separation and purification of echinacoside from Penstemon barbatus (Can.) Roth by recycling high-speed counter-current chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:2665–8
- Yang TX, Lu YX, Guo YH, et al. Studied of dry matter accumulation and echinacoside content of Cistanche tubulosa in Huabei plain. Zhongguo Zhong Yao Za Zhi 2006;31:1317–20
- Jia C, Shi H, Jin W, et al. Metabolism of echinacoside, a good antioxidant, in rats: isolation and identification of its biliary metabolites. Drug Metab Dispos 2009;37:431–8
- Facino RM, Carini M, Aldini G, et al. Echinacoside and caffeoyl conjugates protect collagen from free radical-induced degradation: a potential use of Echinacea extracts in the prevention of skin photodamage. Planta Med 1995;61:510–14
- Kuang R, Sun Y, Zheng X. Suppression of nitric oxide implicated in the protective effect of echinacoside on H2O2-induced PC12 cell injury. Nat Prod Commun 2010;5:571–4
- Zhu M, Zhou M, Shi Y, Li WW. Effects of echinacoside on MPP(+)-induced mitochondrial fragmentation, mitophagy and cell apoptosis in SH-SY5Y cells. Zhong Xi Yi Jie He Xue Bao 2012;10:1427–32
- Zhu M, Lu C, Li W. Transient exposure to echinacoside is sufficient to activate Trk signaling and protect neuronal cells from rotenone. J Neurochem 2013;124:571–80
- Li F, Yang Y, Zhu P, et al. Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. Fitoterapia 2012;83:1443–50
- Geng X, Tian X, Tu P, Pu X. Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease. Eur J Pharmacol 2007;564:66–74
- Wu Y, Li L, Wen T, Li YQ. Protective effects of echinacoside on carbon tetrachloride-induced hepatotoxicity in rats. Toxicology 2007;232:50–6
- Zhang Y, Xing J, Ai T, et al. Protection of echinacoside against acute lung injury caused by oleic acid in rats. Free Radic Res 2007;41:798–805
- Yang X, Li F, Yang Y, et al. Efficacy and safety of echinacoside in a rat osteopenia model. Evid Based Complement Alternat Med 2013;2013:926928
- Li F, Yang X, Yang Y, et al. Antiosteoporotic activity of echinacoside in ovariectomized rats. Phytomedicine 2013;20:549–57
- Wei LL, Chen H, Jiang Y, et al. Effects of echinacoside on histio-central levels of active mass in middle cerebral artery occlusion rats. Biomed Environ Sci 2012;25:238–44
- Feng XY, Zhu M, Zhang QQ, et al. Selective protection of nigral dopaminergic neurons by echinacoside in a rat model of Parkinson disease induced by rotenone. Zhong Xi Yi Jie He Xue Bao 2012;10:777–83
- Jia C, Shi H, Wu X, et al. Determination of echinacoside in rat serum by reversed-phase high-performance liquid chromatography with ultraviolet detection and its application to pharmacokinetics and bioavailability. J Chromatogr B Analyt Technol Biomed Life Sci 2006;844:308–13
- Patel GV, Patel VB, Pathak A, Rajput SJ. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation. Drug Dev Ind Pharm 2014;40:80–91
- Siddhartha TV, Senthil V, Kishan IS, et al. Design and development of oral nanoparticulated insulin in multiple emulsion. Drug Dev Ind Pharm 2014;11:472–85
- Jin X, Zhang ZH, Sun E, et al. A novel drug–phospholipid complex loaded micelle for baohuoside I enhanced oral absorption: in vivo and in vivo evaluations. Drug Dev Ind Pharm 2013;39:1421–30
- Liu Z, Wang J, Gao W, et al. Formulation and in vitro absorption analysis of Rhizoma paridis steroidal saponins. Int J Pharm 2013;441:680–6
- Maiti K, Mukherjee K, Gantait A, et al. Curcumin–phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 2007;330:155–63
- Tan Q, Liu S, Chen X, et al. Design and evaluation of a novel evodiamine–phospholipid complex for improved oral bioavailability. AAPS PharmSciTech 2012;13:534–47
- Peng Q, Zhang ZR, Sun X, et al. Mechanisms of phospholipid complex loaded nanoparticles enhancing the oral bioavailability. Mol Pharm 2010;7:565–75
- Leo A, Hansch C, Elkins D. Partition coefficients and their uses. Chem Rev 1971;71:525–616
- Li H, Zhao X, Ma Y, et al. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release 2009;133:238–44
- Sutton SC, Rinaldi MT, Vukovinsky KE. Comparison of the gravimetric, phenol red, and 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model. AAPS PharmSciTech 2001;3:93–7
- Fagerholm U, Sjostrom B, Sroka-Markovic J, et al. The effect of a drug-delivery system consisting of soybean phosphatidyl choline and medium-chain monoacylglycerol on the intestinal permeability of hexarelin in the rat. J Pharm Pharmacol 1998;50:467–73
- Gurunath S, Nanjwade BK, Patil PA. Oral bioavailability and intestinal absorption of candesartan cilexetil: role of naringin as P-glycoprotein inhibitor. Drug Dev Ind Pharm 2013. [Epub ahead of print]
- Li Y, Jin W, Yan H, et al. Development of intravenous lipid emulsion of vinorelbine based on drug–phospholipid complex technique. Int J Pharm 2013;454:472–7
- Lasonder E, Weringa WD. An NMR and DSC study of the interaction of phospholipid vesicles with some anti-inflammatory agents. J Colloid Interface Sci 1990;2:469–78
- Yanyu X, Yunmei S, Zhipeng C, Qineng P. The preparation of silybin–phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm 2006;307:77–82
- Yi H, Yang Z, Yong-fang Z. The purification and the identification of lecithin and its application. Amino Acids Biotic Resources 2001;23:28–31
- Li Y. Preparation technology and characteristic research on puerarin phospholipids complex in vitro and in vivo. Beijing: Shenyang Pharmaceutical University; 2006
- Guan S, Qin X, Zhou Z, et al. Investigation of the mechanisms of improved oral bioavailability of bergenin using bergenin–phospholipid complex. Drug Dev Ind Pharm 2014;40:163–71
- Han SY, Qiao JQ, Zhang YY, et al. Determination of n-octanol/water partition coefficients of weak ionizable solutes by RP-HPLC with neutral model compounds. Talanta 2012;97:355–61
- Mishra N, Yadav NP, Meher JG, Sinha P. Phyto–vesicles: conduit between conventional and novel drug delivery system. Asian Pac J Trop Biomed 2012;2:S1728–34
- Eedara BB, Veerareddy PR, Jukanti R, Bandari S. Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies. Drug Dev Ind Pharm 2014;40:1030–43
- Salphati L, Childers K, Pan L, et al. Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man. J Pharm Pharmacol 2001;53:1007–13
- Ajazuddin SS. Applications of novel drug delivery system for herbal formulations. Fitoterapia 2010;81:680–9
- Li K, Tang Y, Fawcett JP, et al. Characterization of the pharmacokinetics of dioscin in rat. Steroids 2005;70:525–30
- Oliveira CP, Ribeiro ME, Ricardo NM, et al. The effect of water-soluble polymers, PEG and PVP, on the solubilisation of griseofulvin in aqueous micellar solutions of Pluronic F127. Int J Pharm 2011;421:252–7
- Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971;60:1281–302